Patient experiences with communication about sex during and after treatment for cancer

Psycho-Oncology - Tập 21 Số 6 - Trang 594-601 - 2012
Kathryn E. Flynn1,2, Jennifer Barsky Reese3, Diana D. Jeffery4, Amy P. Abernethy5,6, Li Lin2, Rebecca A. Shelby1, Laura S. Porter1, Carrie B. Dombeck2, Kevin P. Weinfurt1,2
1Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA
2Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
3Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA
4Center for Health Care Management Studies, Health Program Analysis and Evaluation Division, TRICARE Management Activity, US Department of Defense, Bethesda, MD, USA
5Department of Medicine, Duke University School of Medicine, Durham, NC, USA
6Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA

Tóm tắt

AbstractObjective

We studied patients' experiences with oncology providers regarding communication about sexual issues during and after treatment for cancer.

Methods

During development of the Patient‐Reported Outcomes Measurement Information System (PROMIS®) Sexual Function measure, we collected focus group and survey data on communication with oncology professionals about sexual problems. We conducted 16 focus groups with patients and survivors (n = 109) and analyzed the discussions for major themes, including experiences discussing sex during oncology visits. During testing of the PROMIS Sexual Function measure, we assessed experiences discussing sexual problems with oncology professionals (n = 819) and measured bivariate associations between asking for information from clinicians and sexual function and satisfaction with sex life.

Results

Most patients and survivors (74%) thought that discussions with oncology professionals about sexual problems were important, but whether they had ever received information about sexual function from a provider varied by cancer type (23% lung, 29% breast, 39% colorectal, and 79% prostate). Those who had asked an oncology professional about sexual problems had significantly greater interest in sexual activity as well as more sexual dysfunction.

Conclusions

Sexual problems are a widespread concern among patients and survivors, but there is much variation in experiences of communication about sexual issues, and many patients do not receive the information they need from their oncology providers. There are large differences in sexual function between patients who do and do not ask providers about sexual problems. Sexual health has yet to be fully integrated into oncology care, even for cancers involving sex organs.

Copyright © 2011 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

SEER Cancer Statistics Review. In Ries LAG Melbert D Krapcho Met al. (eds) vol 2008. National Cancer Institute: Bethesda MD 1975–2005. Available at:http://seer.cancer.gov/csr/1975_2007/.

National Cancer Institute, 2004, Sexuality and Reproductive Issues (Physician Data Query): Health Professional Version

10.1111/j.1524-4741.2007.00550.x

10.1016/S0738-3991(03)00025-9

10.1002/1097-0142(20010815)92:4 <1008::AID-CNCR1413>3.0.CO;2-2

FlynnKE JefferyDD KeefeFJet al.Sexual functioning along the cancer continuum: focus group results from the Patient‐Reported Outcomes Measurement Information System (PROMIS®). Psycho‐Oncology 2010 Mar 30. [Epub ahead of print] DOI:10.1002/pon.1738.

10.1001/jama.283.3.354

10.1038/sj.bjc.6603454

10.1097/00002820-199608000-00007

10.1016/j.urology.2003.11.029

10.2190/BJV3-BW2A-87BA-MQY6

10.1016/S0167-8140(84)80019-5

10.1016/j.ejon.2005.10.007

10.1188/06.ONF.1163-1167

10.1097/00001622-200409000-00014

10.1038/sj.bjc.6600799

10.1177/107327480100800508

10.1111/j.1743-6109.2009.01620.x

10.1056/NEJMoa067423

10.5694/j.1326-5377.2007.tb00877.x

10.1093/fampra/cmh509

10.1111/j.1743-6109.2006.00385.x

10.1038/sj.ijir.3900948

10.1016/j.fertnstert.2007.08.081

10.1136/bmj.323.7317.836

FlynnKE JefferyDD ReeveBBet al.Progress on the PROMIS® sexual function measure. International Society for Quality of Life Research Annual Conference London England 2010.

Food and Drug Administration.Guidance for industry: patient‐reported outcome measures: use in medical product development to support labeling claims 2006.

10.1097/PPO.0b013e318198c742

10.1080/009262300278597

10.1038/sj.ijir.3900857

10.1016/S0090-4295(97)00238-0

10.1007/s11136-009-9523-x

10.1111/j.1475-6773.2008.00887.x

10.1007/s00520-009-0738-8

10.1007/s00520-010-1000-0